3Williams RV, Minich IL, Tani LY. Phar- macological therapy for patients with Kawasa- ki disease. Paediatr Drugs 2001 ; 3 ( 9 ) : 649 --660o.
4Fukunisbi M, Kikkawa M, Hamana K, et al. Prediction of non - responsiveness to in- travenous high- dose γ - globulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000; 137(2) : 172 - 176.
5Hirata S, Nakanura Y, Yanagawa H. Inci- dence rate of recurrent Kawasaki disease and related risk factors: from the results of na- tionwide surveys of Kawasaki disease in Ja- pan. Acta Paediatr 2001 ;90( 1 ) :40 - 44.
